Key result
Higher liver fat content is linked to ~5% lower Lp(a) levels per 5% increase.
Why the study?
The association between hepatic steatosis and plasma lipoprotein(a) levels remains controversial, and sex- or menopausal status-stratified analyses were lacking.
Is hepatic steatosis, higher liver fat content, and elevated serum transaminases associated with lower serum lipoprotein(a) concentrations in men and women (stratified by menopausal status)?
Cross-Sectional (n=28,711)
Yes
Is hepatic steatosis, higher liver fat content, and elevated serum transaminases associated with lower serum lipoprotein(a) concentrations in men and women (stratified by menopausal status)?
Answers are grounded in this paper and cite their sources.
Hepatic steatosis and higher liver fat content are independently associated with lower lipoprotein(a) concentrations in men and postmenopausal women, which may affect cardiovascular risk evaluation in patients with metabolic dysfunction.
Background Higher lipoprotein(a) (Lp[a]) levels are considered a cardiovascular risk factor1 and are accepted to be genetically determined,2 to remain generally stable throughout life, except in postmenopausal females,3 and to be less affected by age, sex, or body weight.4 On the other hand, the liver synthesizes the Lp(a). It is possible that damage to this organ, caused by metabolic dysfunction conditions, compromises this production. The association between hepatic steatosis (HS) and plasma lipoprotein(a) (Lp[a]) levels remains controversial, with no sex- or menopausal status-stratified analyses. Purpose The purpose of the present study was to analyze the sex- and menopausal status-specific associations of HS and serum transaminases with Lp(a) concentrations in the United Kingdom (UK) Biobank study. Methods We analysed cross-sectional data from 28,711 individuals (15,024 women) aged 40 to 70 years from the UK Biobank study. We examined sex- and menopausal status-specific associations of HS and liver fat content (LFC), determined by magnetic resonance imaging, and serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) with serum log-transformed Lp(a) concentrations using linear regression models adjusted for age, body mass index, hemoglobin A1c, glucose-lowering medication use, hypertension, smoking, and alcohol consumption. HS was defined as LFC ≥ 5%. The results of the regression analyses were presented as geometric mean (GM) ratio with 95% confidence intervals. Results In the UK Biobank study, men with HS had a 9% (95% confidence interval [CI]: 5% to 13%; p<0.001) lower log-transformed Lp(a) concentrations than those without HS in UK Biobank. Moreover, a 5% higher LFC was associated with a 5% (95% CI: 3% to 7%; p<0.001) lower log-transformed Lp(a) concentrations. Additionally, a 1 µkatal/L higher ALT, and AST level was associated with a 15% (95% CI: 5% to 25%; p=0.005) and a 20% (95% CI: 5% to 34%; p=0.012) lower log-transformed Lp(a) concentrations. There was no association with GGT levels. Higher LFC was also associated with lower Lp(a) concentrations in women, but HS and serum liver enzymes were not (Table 1). After stratification by menopausal status, higher LFC was associated with lower log-transformed Lp(a) concentrations in postmenopausal women, but not in premenopausal women. Specifically, a 5% higher LFC was associated with a 4% (95% CI: 1% to 7%; p=0.018) lower log-transformed Lp(a) concentrations in postmenopausal women (Table 2). Conclusions Our findings from a large community-based study indicate that HS and higher LFC, ALT and AST were independently associated with lower Lp(a) concentrations in men. Additionally, LFC was also associated with lower Lp(a) concentrations in postmenopausal women. Future studies should analyze how to evaluate the increased cardiovascular risk of patients with metabolic dysfunction conditions when Lp(a) levels are reduced.
No takes yet. Share an insight, caveat, or question.
Markus et al. (2026) conducted a cross-sectional in Hepatic steatosis and elevated liver fat content (n=28,711). Hepatic steatosis (liver fat content ≥ 5%), liver fat content, and serum transaminases (ALT, AST, GGT) vs. Absence of hepatic steatosis (liver fat content < 5%) or lower liver fat/enzyme levels was evaluated on Serum log-transformed lipoprotein(a) [Lp(a)] concentrations (9% lower (men with HS); 5% lower per 5% higher LFC (men); 4% lower per 5% higher LFC (postmenopausal women), 95% CI 5% to 13% (men with HS); 3% to 7% (men LFC); 1% to 7% (postmenopausal women LFC), p=<0.001). Higher liver fat content was associated with lower Lp(a) levels in men and postmenopausal women.
Synapse has enriched 10 related papers. Consider them for comparative context: